Keeping Current

Keeping Current

Medscape Podcasts
Country USA
Language EN
Episodes 622
Latest 10.11.2026

Keeping Current is a medical podcast from Medscape Podcasts where experts discuss timely clinical topics. Each episode offers actionable strategies for practice improvement, helping clinicians stay up to date with relevant evidence and patient care approaches.

Episodes

  • Polypoidal Choroidal Vasculopathy: How Second-Generation Therapies Are Redefining Outcomes
    Polypoidal Choroidal Vasculopathy: How Second-Generation Therapies Are Redefining Outcomes 10.11.2026 34m
    Explore the latest breakthroughs, guidance and treatment strategies in polypoidal choroidal vasculopathy (PCV). Credit available for this activity expires: 11/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/polypoidal-choroidal-vasculopathy-how-second-generation-2026a100155b?ecd=bdc_podcast_libsyn_mscpedu
  • Oral vs Injectable: Navigating Patient Choice in Weight Management
    Oral vs Injectable: Navigating Patient Choice in Weight Management 06.11.2026 23m
    Discover oral incretins as alternatives in obesity care. Credit available for this activity expires: 11/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/oral-vs-injectable-navigating-patient-choice-weight-2026a10014pl?ecd=bdc_podcast_libsyn_mscpedu
  • European Alzheimer's Care: A Live, Case-Based Forum on Amyloid-Targeting Therapy
    European Alzheimer's Care: A Live, Case-Based Forum on Amyloid-Targeting Therapy 26.10.2026 55m
    How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice? Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/european-alzheimers-care-live-case-based-forum-amyloid-2026a1001215?ecd=bdc_podcast_libsyn_mscpedu
  • Deciphering Clinical Data in Transthyretin Cardiac Amyloidosis for Today's Clinical Practice
    Deciphering Clinical Data in Transthyretin Cardiac Amyloidosis for Today's Clinical Practice 20.10.2026 31m
    Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/deciphering-clinical-data-transthyretin-cardiac-amyloidosis-2026a100110n?ecd=bdc_podcast_libsyn_mscpedu
  • Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer
    Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer 13.10.2026 28m
    A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening? Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010phecd=bdc_podcast_libsyn_mscpedu
  • Navigating IgA Nephropathy Management in an Evolving Treatment Landscape: Key Considerations for Treatment Selection
    Navigating IgA Nephropathy Management in an Evolving Treatment Landscape: Key Considerations for Treatment Selection 13.10.2026 45m
    Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression. Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-nephropathy-management-evolving-treatment-2026a10010le?ecd=bdc_podcast_libsyn_mscpedu
  • Antibody-Drug Conjugate Therapy for Early Breast Cancer: Innovations That Shape the Future of Care
    Antibody-Drug Conjugate Therapy for Early Breast Cancer: Innovations That Shape the Future of Care 06.10.2026 31m
    ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therapy-early-breast-cancer-2026a10010lp?ecd=bdc_podcast_libsyn_mscpedu
  • Solving the Alzheimer's Disease Biomarker Puzzle: Live, European Peer Workshop
    Solving the Alzheimer's Disease Biomarker Puzzle: Live, European Peer Workshop 28.09.2026 36m
    Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podcast_libsyn_mscpedu
  • Advancing Uveitic Macular Edema Management: What's New?
    Advancing Uveitic Macular Edema Management: What's New? 28.09.2026 32m
    Do you know how to meet the challenges of treating uveitic macular edema? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_libsyn_mscpedu
  • Patient Journeys With IgA Nephropathy: Optimizing Outcomes in Patient Care
    Patient Journeys With IgA Nephropathy: Optimizing Outcomes in Patient Care 25.09.2026 59m
    Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management. Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outcomes-patient-2026a1000xq5?ecd=bdc_podcast_libsyn_mscpedu
  • Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era
    Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era 24.09.2026 52m
    How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more. Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-her2-negative-early-2026a1000ysl?ecd=bdc_podcast_libsyn_mscpedu
  • The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases: Exploring the Potential for CAR T-Cell Therapies
    The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases: Exploring the Potential for CAR T-Cell Therapies 22.09.2026 48m
    Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases? Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1000xbu?ecd=bdc_podcast_libsyn_mscpedu
  • Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer
    Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer 22.09.2026 35m
    Are you up to speed on the latest updates on molecular-guided therapies in HR-positive/HER2-negative metastatic breast cancer (MBC)? Join us to learn more. Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/translating-molecular-insights-practice-hr-positive-her2-2026a1000y0g?ecd=bdc_podcast_libsyn_mscpedu
  • Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health
    Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health 08.09.2026 29m
    Discover how emerging targeted therapies address systemic drivers in MASLD and MASH. Credit available for this activity expires: 9/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/targeting-metabolic-driver-forward-looking-approach-obesity-2026a1000t0l?ecd=bdc_podcast_libsyn_mscpedu
  • The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis
    The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis 04.09.2026 42m
    Fatigue, unpredictability, and life goals; integrate what patients say they need into how you treat myasthenia gravis (MG). Credit available for this activity expires: 9/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/whole-patient-integrating-lived-experience-myasthenia-gravis-2026a1000rf7?ecd=bdc_podcast_libsyn_mscpedu
  • Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start
    Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start 01.09.2026 47m
    Are your epilepsy patients achieving true seizure freedom, or is it time to adjust their therapy? Credit available for this activity expires: 9/1/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/epilepsy-general-neurology-practice-optimizing-therapeutic-2026a1000rgh?ecd=bdc_podcast_libsyn_mscpedu
  • Myasthenia Gravis Guidelines: A Global View for Local Practice
    Myasthenia Gravis Guidelines: A Global View for Local Practice 19.08.2026 38m
    Compare global myasthenia gravis (MG) guidelines to optimize local, patient-centered treatment pathways. Credit available for this activity expires: 8/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/myasthenia-gravis-guidelines-global-view-local-practice-2026a1000q15?ecd=bdc_podcast_libsyn_mscpedu
  • From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic
    From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic 18.08.2026 18m
    Are non-factor therapies enough to protect your hemophilia A patients during surgery? Credit available for this activity expires: 8/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanism-management-applying-evidence-hemophilia-clinic-2026a1000p5z?ecd=bdc_podcast_libsyn_mscpedu
  • Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring
    Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring 14.08.2026 41m
    Master multimodality imaging and autonomic red flag screening in your transthyretin amyloid cardiomyopathy (ATTR-CM) practice. Episode learning points & Disclosures: https://www.medscape.org/viewarticle/updating-our-checklist-transthyretin-amyloid-cardiomyopathy-2026a1000pul?ecd=bdc_podcast_libsyn_mscpedu
  • Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late?
    Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late? 07.08.2026 39m
    What tests are best to assess early cognitive symptoms? Credit available for this activity expires: 03/05/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003254?ecd=bdc_podcast_libsyn_mscpedu

Popular in

The podcast also appears in the podcast charts of these countries.